Search results
Results from the WOW.Com Content Network
Tuberculosis is one of India's biggest health issues, but what makes this problem even worse is the recent discovery of Totally Drug-Resistant Tuberculosis, TDR-TB. This issue of drug resistance began with MDR-TB , moved to XDR-TB and, as of 2021, has grown to embrace the most dangerous form, TDR-TB .
The National Tuberculosis Institute (NTIB) [1] is a Government of India institute, under the Directorate General of Health Services, Ministry of Health and Family Welfare, dedicated to advanced research on Tuberculosis.
M. tuberculosis is able to reproduce inside the macrophage and will eventually kill the immune cell. The primary site of infection in the lungs, known as the Ghon focus, is generally located in either the upper part of the lower lobe, or the lower part of the upper lobe. [13] Tuberculosis of the lungs may also occur via infection from the blood ...
In India a sizable proportion of the people with symptoms suggestive of pulmonary tuberculosis approach the private sector for their immediate health care needs. However, the private sector is overburdened, and lacks the capacity to treat such high volumes of patients.
According to a 2013 review, tuberculosis elimination will require not just treating active tuberculosis but also latent cases, and eliminating tuberculosis by 2050 worldwide is not possible, although great reductions in infections and deaths are possible. [3] Addressing poverty is a further requirement for eliminating tuberculosis.
The National Institute for Research in Tuberculosis (NIRT) is a tuberculosis research organization located in Chennai, Tamil Nadu. NIRT carries out research on clinical, bacteriological as well as behavioural and epidemiological aspects of tuberculosis and HIV-TB.
The National Institute of Epidemiology (NIE) is a medical research organisation located in Chennai, Tamil Nadu. NIE conducts research including interventional studies, disease modelling and health systems, conducts epidemiological investigations and clinical trials of traditional remedies.
Pai is a frequent media commentator on the COVID-19 pandemic in India, [13] [2] [14] and in 2021 drew comparisons of the collective global action taken in response to the COVID19 pandemic versus the relative inaction towards tuberculosis. [15] His 2021 paper in PLOS Medicine addressed power asymmetries in global health. [16]